Company Overview:
ars pharmaceuticals inc - SPRY
SPRY Key Data
| Open $5.55 | Day Range 5.11 - 5.60 |
| 52 Week Range 5.11 - 18.00 | Market Cap $695.12M |
| Shares Outstanding 99.30M | Public Float 64.50M |
| Beta 0.94 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$2.00 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.22M |
|
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | | Average Target Price | 26.75 |
| Number of Ratings | 4 | | Current Quarters Estimate | -0.291 |
| FY Report Date | 09 / 2026 | | Current Year's Estimate | -1.726 |
| Last Quarter’s Earnings | -0.498 | | Median PE on CY Estimate | N/A |
| Year Ago Earnings | -1.74 | | Next Fiscal Year Estimate | -0.93 |
| | | Median PE on Next FY Estimate | N/A |
Earnings Per Share
|
This Quarter
|
Next Quarter
|
This Fiscal
|
Next Fiscal
|
|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | -0.29 | -0.37 | -1.73 | -0.93 |
| High Estimates | -0.10 | -0.15 | -1.05 | -0.62 |
| Low Estimate | -0.39 | -0.54 | -2.05 | -1.41 |
| Coefficient of Variance | -45.76 | -48.00 | -26.58 | -39.52 |
Analysts Recommendations
|
Current
|
1 Month Ago
|
3 Months Ago
|
|---|
| BUY |
4
|
4
|
7
|
| OVERWEIGHT |
0
|
0
|
0
|
| HOLD |
0
|
0
|
0
|
| UNDERWEIGHT |
0
|
0
|
0
|
| SELL |
0
|
0
|
0
|
| MEAN |
Buy
|
Buy
|
Buy
|
An error occurred while fetching the data.